Danielle Hing
YOU?
Author Swipe
View article: Personalized Monitoring of Response to Anti‐Amyloid Therapy in a Real‐World Cohort using Clinical Assessment and Plasma Biomarkers
Personalized Monitoring of Response to Anti‐Amyloid Therapy in a Real‐World Cohort using Clinical Assessment and Plasma Biomarkers Open
Background Blood‐based biomarkers may be a cost‐effective, accessible method for monitoring response to anti‐amyloid therapy (AAT). While plasma biomarkers of Alzheimer’s disease pathology correlate with amyloid and tau measures on PET and…
View article: Microstructural and Water Exchange Alterations in ARIA‐E in a Real‐World Cohort Receiving Anti‐Amyloid Therapy
Microstructural and Water Exchange Alterations in ARIA‐E in a Real‐World Cohort Receiving Anti‐Amyloid Therapy Open
Background ARIA‐E represents the greatest risk associated with anti‐amyloid therapy (AAT) and is thought to be due to excessive inflammatory response resulting in FLAIR abnormalities on imaging and occasionally symptomatic manifestations. …
View article: Segmentation and Quantification of Perivascular Spaces in Early Alzheimer’s Disease using Ultra‐long TE T2‐weighted MRI
Segmentation and Quantification of Perivascular Spaces in Early Alzheimer’s Disease using Ultra‐long TE T2‐weighted MRI Open
Background Perivascular spaces (PVS) are small fluid‐filled structures that are of major interest in both cerebral small vessel disease (cSVD) and neurodegeneration, particularly in the pathophysiology of AD and cerebral amyloid angiopathy…
View article: Monitoring Cognition in Patients Undergoing Anti‐Amyloid Therapies with A Remote App‐Based Digital Cognitive Assessment Tool
Monitoring Cognition in Patients Undergoing Anti‐Amyloid Therapies with A Remote App‐Based Digital Cognitive Assessment Tool Open
Background Mobile, valid and engaging cognitive assessments are essential for detecting and tracking change in cognition. With the approval of anti‐amyloid therapies (AATs), there is a need to monitor for both benefits and risks of these t…
View article: Amyloid‐accumulating cortical regions show selectively greater longitudinal thinning in the presence of ARIA during anti‐amyloid therapy
Amyloid‐accumulating cortical regions show selectively greater longitudinal thinning in the presence of ARIA during anti‐amyloid therapy Open
Background Paradoxical reductions in brain volume in individuals with Alzheimer’s disease treated with anti‐amyloid therapy have been reported in clinical trials. It has been hypothesized that these changes could partly be attributed to pr…
View article: Monitoring Cognition in Patients Undergoing Anti‐Amyloid Therapies with A Remote App‐Based Digital Cognitive Assessment Tool
Monitoring Cognition in Patients Undergoing Anti‐Amyloid Therapies with A Remote App‐Based Digital Cognitive Assessment Tool Open
Background Mobile, valid and engaging cognitive assessments are essential for detecting and tracking change in cognition. With the approval of anti‐amyloid therapies (AATs), there is a need to monitor for both benefits and risks of these t…